companydata.dkcompanydata.dk

DRUGRECURE ApS: Financial statements 2012

CVR: 29154406

Source: annual report 2012, Danish Business Authority

01/01/2012 – 31/12/2012

DRUGRECURE ApS (CVR 29154406) has filed annual accounts for 2012. In 2012, the company reported a net result of DKK -22,108. Equity in the 2012 report amounted to DKK 4,646,765. The solvency ratio was 53%.

Profit/Loss
DKK -22,108
Equity
DKK 4,646,765
Total Assets
DKK 8,770,035

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on DRUGRECURE ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2012

Lars Heslet leaves the board of DRUGRECURE ApSJun 21, 2012

As of June 21, 2012, Lars Heslet has left the board of directors of DRUGRECURE ApS.

Eric Jean Marie Leire leaves the board of DRUGRECURE ApSJun 21, 2012

As of June 21, 2012, Eric Jean Marie Leire has left the board of directors of DRUGRECURE ApS.

About DRUGRECURE ApS

DRUGRECURE ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2005. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named ApS KBUS 17 NR. 4495. The management consists of Danielle Marie Brown. The company is owned by Savara ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -231,083,000 and a net result of DKK -282,428,000 compared with DKK -274,629,000 the year before. Equity in the 2025 report amounted to DKK -1,360,145,000.

Source: annual report 2025, Danish Business Authority